card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Building a Best-in-Class Model for Global CDx Clinical Trial Deployment

11th Annual World Clinical Biomarkers & CDx Summit
Home / Insights / Building a Best-in-Class Model for Global CDx Clinical Trial Deployment

Alan Wookey, Companion Diagnostics and Oncology Scientific Advisor at IQVIA Laboratories along with Kristina McGuire, Sr. Director & Head of CDx and Lab operations at Regeneron and Shirin Hasan, Associate, Vice President Head of Global Clinical Affairs at Agilent and Trevor Page, Chief Business Officer, Companion Diagnostics at Agilent deliver a shared vision on building a best-in-class model for global CDx clinical trial deployment. 

The panel discussion will cover the following topics:

  • The intricacies of the partnership between pharmaceutical/biotechnology drug developer, the clinical central lab and the diagnostic company that lead to a successful global Dx/CDx launch
  • How the field of companion diagnostics has changed from the beginning of a program to the finish line
  • The novel and creative approaches needed to enable a successful CDx program
  • How to maintain the highest level of data integrity across multiple organizations on a global scale


Download the presentation slides or watch the full panel discussion including the Q&A session